VCEL Vericel Corporation
Vericel Corporation (VCEL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 94% planned / 6% discretionary
Largest single sale: $684.6K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| MCLAUGHLIN KEVIN F | Director | Sell 10b5-1 | 7,000 | $44.53 | $311.7K | 18,300 −27.7% of holding | |
| Halpin Michael | Chief Operating Officer | Sell 10b5-1 | 10,000 | $46.84 | $468.4K | 16,394 −37.9% of holding | |
| SIEGAL JONATHAN 3 fills | Principal Accounting Officer | Sell 10b5-1 | 4,500 | $48.90 | $220.1K | 1,078 −80.7% of holding | |
| Flynn Sean C. | Chief Legal Officer | Sell 10b5-1 | 15,000 | $45.64 | $684.6K | 1,647 −90.1% of holding | |
| Hopper Jonathan Mark 2 fills | Chief Medical Officer | Sell 10b5-1 | 10,000 | $45.00 | $450.0K | 75,753 −11.7% of holding | |
| Mara Joseph Anthony Jr | Chief Financial Officer | Sell 10b5-1 | 5,000 | $44.75 | $223.8K | 16,009 −23.8% of holding | |
| SIEGAL JONATHAN 2 fills | Principal Accounting Officer | Sell 10b5-1 | 2,732 | $44.90 | $122.7K | 886 −75.5% of holding | |
| Flynn Sean C. | Chief Legal Officer | Sell 10b5-1 | 15,000 | $40.21 | $603.2K | 1,647 −90.1% of holding | |
| Halpin Michael | Chief Operating Officer | Sell 10b5-1 | 10,000 | $40.24 | $402.4K | 16,248 −38.1% of holding | |
| Hopper Jonathan Mark | Chief Medical Officer | Sell 10b5-1 | 4,375 | $35.00 | $153.1K | 75,753 −5.5% of holding | |
| MCLAUGHLIN KEVIN F 2 fills | Director | Sell 10b5-1 | 7,000 | $32.83 | $229.8K | 18,300 −27.7% of holding | |
| Wotton Paul K 2 fills | Director | Sell | 10,000 | $32.74 | $327.4K | 26,302 −27.5% of holding | |
| Mara Joseph Anthony Jr | Chief Financial Officer | Sell 10b5-1 | 5,000 | $40.50 | $202.5K | 21,009 −19.2% of holding | |
| SIEGAL JONATHAN | Principal Accounting Officer | Sell 10b5-1 | 1,422 | $40.50 | $57.6K | 1,118 −56% of holding | |
| SIEGAL JONATHAN | Principal Accounting Officer | Sell 10b5-1 | 3,433 | $38.00 | $130.5K | 2,540 −57.5% of holding | |
| Hopper Jonathan Mark | Chief Medical Officer | Sell 10b5-1 | 3,472 | $35.00 | $121.5K | 75,556 −4.4% of holding | |
| Hagen Heidi | Director | Sell 10b5-1 | 15,000 | $32.41 | $486.2K | 31,850 −32% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.